Point of View Simulation for Stigma
(point of view Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to reduce stigma around opioid use by training healthcare professionals to better understand and manage pain in sickle cell patients. Point of view simulations foster empathy among pharmacists by allowing them to experience interactions from the patient's perspective. This can improve their view and treatment of patients using opioids. The trial is ideal for healthcare professionals or students who fill opioid prescriptions and seek to enhance their care approach. As an unphased trial, participants contribute to innovative educational methods that improve patient care and empathy.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications.
What prior data suggests that this simulation is safe for pharmacists?
Previous studies have shown that training with simulations reduces stigma among healthcare professionals. Research indicates that these simulations can change attitudes by helping participants understand and empathize with patients' experiences. For instance, healthcare students who underwent similar training reported a better understanding of conditions like substance use disorders when viewing them as diseases. This suggests that point-of-view simulations could reduce bias and improve empathy without harming participants.
Since this trial uses a point-of-view simulation, a type of educational tool, there is little risk of physical harm. Participants interact with a computer-based program, focusing on changing perceptions through mental engagement rather than any physical procedure. This makes participation very safe.12345Why are researchers excited about this trial?
Researchers are excited about the Point of View Simulation for stigma because it offers a novel approach to tackling misconceptions about opioid use among pharmacists. Unlike traditional educational methods that focus on didactic learning, this simulation actively engages participants by immersing them in the perspectives of others, potentially fostering greater empathy and understanding. This experiential learning technique could lead to more compassionate pharmacy practices, particularly for patients with conditions like sickle cell disease who require opioid medications. By focusing on changing attitudes and behaviors, the simulation aims to create a more supportive and understanding healthcare environment.
What evidence suggests that this point of view simulation is effective for reducing stigma in pain management?
Research has shown that simulations, such as the Point of View Simulation tested in this trial, can help healthcare professionals understand a patient's perspective and reduce stigma. Studies have found that these simulations can change how students and professionals perceive individuals with conditions like addiction. By adopting the patient's viewpoint, participants can become more empathetic. This increased empathy helps reduce misunderstandings and improves care. Although specific data on sickle cell patients and stigma related to opioid use is limited, this approach has shown promise in similar areas. Early results suggest that these simulations could be a useful tool for promoting empathy in healthcare.12467
Who Is on the Research Team?
Nicholas L Denton, PhD
Principal Investigator
Ohio State University College of Pharmacy
Are You a Good Fit for This Trial?
This trial is for pharmacy and hospital staff, as well as nursing and pharmacy students who are involved in pain management for sickle cell patients. The goal is to enhance empathy-based practices to reduce stigma associated with opioid use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Simulation Implementation
Participants complete a point of view simulation activity to reduce misconceptions about opioid use.
Post-Simulation Survey
Participants complete a survey to assess changes in misconceptions about opioid use.
Follow-up
Participants' practice sites are evaluated for empathy-based care practices by sickle cell disease patient evaluators.
What Are the Treatments Tested in This Trial?
Interventions
- Point of View Simulation
Trial Overview
The study tests a new training method using point of view simulations on computers. It aims to see if this approach can improve pharmacists' understanding of sickle cell patients' experiences with chronic pain and their management.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Participating pharmacists in the experimental arm will receive an email invitation to complete a 16-item pre-survey around opioid use misconceptions before completing the point of view simulation activity. 10 days after participants complete the simulation they will be invited to complete the opioid misconception survey again as a post-learning intervention assessment. 6 months after participants complete the simulation, their practice site will be visited by a sickle cell disease patient evaluator who will refill their opioid medication with the pharmacist and then complete an 11-item evaluation survey on the pharmacist's empathy-based pharmacy practices.
Participating pharmacists in the sham arm will receive an email invitation to complete a 16-item pre-survey around opioid use misconceptions before completing an unrelated hematology educational activity. 10 days after participants complete the simulation they will be invited to complete the opioid misconception survey again as a post-learning intervention assessment. 6 months after participants complete the simulation, their practice site will be visited by a sickle cell disease patient evaluator who will refill their opioid medication with the pharmacist and then complete an 11-item evaluation survey on the pharmacist's empathy-based pharmacy practices.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Howard University
Collaborator
Fairleigh Dickinson University
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator
Citations
Solving Stigma Through POV Simulation: Enhancing ...
The researchers will test if point of view simulations can reduce misconceptions among healthcare professionals and improve pain management for ...
Health professions students' perspectives of a stigma- ...
This study explores perceptions of health professions students following simulation-based training involving individuals with lived experience of addiction and ...
Effect of Exposure to Visual Campaigns and Narrative ...
This randomized clinical trial assesses the effects of visual campaigns with and without written narrative vignettes on stigma and attitudes ...
Effect of Exposure to Visual Campaigns and Narrative ...
The findings of this randomized clinical trial suggest that carefully designed communication campaigns may reduce OUD-related stigma among health care ...
Health professions students• perspectives of a stigma- ...
This study explores perceptions of health professions students following simulation-based training involving individuals with lived experience of addiction and ...
Healthcare Professional Students' Perspectives on Substance ...
Thematic Analysis revealed one theme (1) Decreasing stigma among healthcare professionals by viewing substance use disorder as a disease; and two sub-themes.
7.
harmreductionjournal.biomedcentral.com
harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00589-6evaluating an opioid overdose prevention training program ...
Our innovative OOPP was effective not only in increasing knowledge but also in improving attitudes towards overdose reversal and reducing stigma ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.